Identifying patients at risk: multi‐centre comparison of HeartMate 3 and HeartWare left ventricular assist devices

AIMS: Since the withdrawal of HeartWare (HVAD) from the global market, there is an ongoing discussion if and which patients require prophylactically exchange for a HeartMate 3 (HM3). Therefore, it is important to study outcome differences between HVAD and HM3 patients. Because centres differ in pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Numan, Lieke, Zimpfer, Daniel, Zadok, Osnat Itzhaki Ben, Aarts, Emmeke, Morshuis, Michiel, Guenther, Sabina P.W., Riebandt, Julia, Wiedemann, Dominik, Ramjankhan, Faiz Z., Oppelaar, Anne‐Marie, Ben‐Gal, Tuvia, Ben‐Avraham, Binyamin, Asselbergs, Folkert W., Schramm, Rene, Van Laake, Linda W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10192248/
https://www.ncbi.nlm.nih.gov/pubmed/36798028
http://dx.doi.org/10.1002/ehf2.14308

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10192248/
https://www.ncbi.nlm.nih.gov/pubmed/36798028
http://dx.doi.org/10.1002/ehf2.14308

Ejemplares similares